#bioprocessing
Link
The current focus of the users of this novel technology is primarily on upgrading individual operations to the continuous mode; as indicated earlier, some companies have already established bioprocessing lines with multiple continuous processes. Cost, (end product) quality, processing speed and operational flexibility are some of the primary driving factors of the gradual shift to continuous bioprocessing. The COVID-19 pandemic has also contributed to accelerating the adoption of continuous flow systems. Some of the existing challenges in this field include complexities related to defining continuous processes (especially those upstream to the fermentation step), and aligning the available equipment to operate as per current GMP requirements. Although an end-to-end continuous bioproduction line is still several years away, we believe that the opportunity for both innovators and service providers engaged in this domain is likely to grow in the foreseen future.
2 notes
·
View notes
Text
Products are getting better and better. How do you think?
#CEKG#Bioreactor#bioprocessing#upstream#VirusVaccines#AdenovirusVector#Protein-based#Vaccines#VLP#biotechnology#biotechindustry#biodefence#biofuels#biological#biopharmaceuticals
1 note
·
View note
Text
Europe Single-use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred Tank, Wave Induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User - Forecast to 2030
#Europe Single-use Bioreactors Market#Single-use Bioreactors Market#Single-use Bioreactors#cell culture#cell therapy#gene therapy#bioprocess#bioprocessing#bioproduction#biotechnology
0 notes
Text
#bioprocessing#marketresearchfirm#marketresearchcompany#bufferexchange#bufferexchangeinbioprocessing
0 notes
Text
1 note
·
View note
Text
#EnzymeMarket#SpecialtyEnzymes#Biotechnology#EnzymeIndustry#Biochemistry#IndustrialEnzymes#Bioprocessing#EnzymeApplications#EnzymeInnovation#BiotechSolutions
0 notes
Text
CellRev sign JDA with Saint-Gobain Life Sciences to develop a ground-breaking media rejuvenation process
CellRev, the bioprocessing company revolutionising adherent cell cultivation, has signed a joint development agreement (JDA) with Saint-Gobain Life Sciences to develop a pioneering process for media rejuvenation.
The JDA which utilises the bioprocessing expertise of CellRev and the filtration know-how of Saint-Gobain Life Sciences (SGLS), will initiate development of a solution that can remove…
View On WordPress
0 notes
Text
Revolutionizing biotech: Biogene's Cylindrical Autoclave, Seed Fermenter, nurturing breakthroughs in just one efficient vessel.
Visit Here For More:- https://bit.ly/3OulR27
#BioGeneCylindricalAutoclave #SeedFermenter #BioTechEquipment #LabInnovation #SustainableResearch #BiotechLabTools #AdvancedFermentation #Bioprocessing #SeedScience #AutoclaveTech #FermentationSolutions #BioTechAdvancements #SeedCulture #LabResearch #BiotechEngineering #InnovativeTechnology
#BioGeneCylindricalAutoclave#SeedFermenter#BioTechEquipment#LabInnovation#SustainableResearch#BiotechLabTools#AdvancedFermentation#Bioprocessing#SeedScience#AutoclaveTech#FermentationSolutions#BioTechAdvancements#SeedCulture#LabResearch#BiotechEngineering#InnovativeTechnology
0 notes
Photo
In a small, sterile room, a team of scientists pours over a complex formula. The future of the company rests on their shoulders, as they race to perfect a new product that will revolutionize the industry. The clock ticks. The pressure mounts. They must succeed. Suddenly, one of the scientists shouts in triumph. They have found the solution. The others quickly join in, excitedly discussing the implications of their discovery. This is it. They have done it. And with that, the future of the company is secured.
0 notes
Link
Over time, biologics have gained significant popularity owing to their therapeutic efficacy, favorable safety profiles and ability to treat a wide variety of disease indications, which are otherwise hard to treat. The success of these interventions has prompted the stakeholders to upgrade the traditional biologics manufacturing technology. The demand for increasing productivity and flexibility, greater profitability and faster time to market are further driving the replacement of traditional stainless-steel equipment with single-use technologies.
0 notes
Text
#LabEquipment#DrugDiscovery#DrugDevelopment#ScientistChoiceAwards#biologics#biopharma#lifescience#biotechnology#bioprocessing#LaboratoryEquipment#LabProducts
1 note
·
View note
Link
Humans have been manipulating live microorganisms to produce food for thousands of years: 2.000 years ago we started to produce bread from yeast. Since then, we learned biotechnology intuitively and without fully understanding the processes, though today is another story.
Tec de Monterrey's FEMSA Biotechnology Center carries out more than 200 projects a year. It has a staff of researchers from all over the country
What is biotechnology?
More than science fiction, biotechnology is a modern science whose foundations are based on technologies that exploit the biological mechanisms and interactions of living beings. And their applications promise to make life easier. We tell you why.
Applications of biotechnology
Biotechnology starts with the discovery of DNA structure to selectively modify the activity of living organisms. Thus, the design of microorganisms to achieve antibiotics, the creation of microbes to produce chemicals, and cultures of transgenic plants resistant to adverse climatic conditions are some of their applications. Biotechnology is part of a large part of industrial and pharmaceutical processes.
In Mexico, there is a place that has been dedicated to promoting this area of knowledge in Mexico. This is the FEMSA Biotechnology Center of the Tecnologico de Monterrey.
The Biotechnology Centre is a research space for the future. Its creation arose out of the efforts of researchers such as Mario Moises Alvarez and Marco Rito Palomares with the idea of doing science in the country.
"It was at a meeting of professors when the then rector Rafael Rangel Sostmann decided to bet on our work and our desire to do science," recalls Dr. Rito Palomares.
The project began with a modest laboratory equivalent to two classrooms on the Monterrey Campus. They had fewer than 10 students. “We were three researchers with the dream of generating a completely new building, and we started a funding campaign,” says Marco Rito.
One and a half years after the project began, they reached the goal of financing its construction. In a couple of years it was crystallized into what is now a five-level building, with first-world infrastructure, which has allowed it to attract talent from Mexico and the whole planet.
Improving the health of humanity
The Center focuses on nutrigenomics and bioprocesses—to build the foundations of the food of the future—as well as synthetic biology—to create products that can have a proven impact on health.
Their big bet is to develop pharmaceuticals and build the basis for food with cutting-edge and innovative research.
Nutrigenomics could help combat modern pandemics that now require reconciliation between the body and a diet as genes command it. Researchers yearn that we can have in a food the way to prevent cancer, or that in a simple salad there are all the nutrients and vitamins that our body requires.
The results could not only revolutionize the food industry, they would also mean considerable savings in public spending on health disorders around the world.
“The main concern is the identification of compounds that can be incorporated into food and that can have a proven impact on health. From a cookie or yogurt with unique antioxidant capabilities that stop cell deterioration,” explains Dr. Rito Palomares.
Institutional collaboration
Today, the FEMSA Center has a staff of more than 150 researchers who have been able to attract talent from all over the country. It also has a network of collaboration with other universities that is strengthened by the exchange of students, and the development and presentation of joint projects.
It also has different collaborations with universities such as the National Autonomous University of Mexico.
Unique achievements
Some credentials of this center are:
At CB-FEMSA, about 200 projects are carried out each year.
The investment for each project is between 100,000 to one million dollars.
Technology in drugs increases the efficiency and speed with which they act.
CB-FEMSA has obtained, in total, 100 patents in the areas of food, anticancer and antioxidant products, among others.
#🇲🇽#STEM#mexico#Mario Moises Alvarez#Marco Rito Palomares#Rafael Rangel Sostmann#mexican#latino#hispanic#biotechnology#food#Tec de Monterrey#FEMSA Biotechnology Center#nutrigenomics#bioprocesses#synthetic biology#Autonomous University of Mexico#UNAM
2 notes
·
View notes
Text
Next-Generation Single Use Assemblies: Advancing Biopharmaceutical Manufacturing
Introduction:
Single Use Assemblies have emerged as a game-changing technology in the field of biopharmaceutical manufacturing, offering numerous advantages over traditional stainless steel equipment.
In this blog, we delve into the latest advancements in Single Use Assemblies and how they are driving innovation and efficiency in biopharmaceutical manufacturing processes.
Enhanced Design and Functionality:
Next-generation Single Use Assemblies feature enhanced design and functionality, incorporating innovations in materials, engineering, and manufacturing processes.
These assemblies are engineered to meet the specific needs of biopharmaceutical manufacturers, providing improved performance, reliability, and ease of use.
Advanced designs offer increased flexibility, scalability, and compatibility with a wide range of bioprocessing applications and equipment.
Integrated Sensor Technology:
Next-generation Single Use Assemblies are equipped with integrated sensor technology that allows for real-time monitoring and control of critical process parameters.
Sensors embedded within the assembly provide valuable data on temperature, pressure, pH, conductivity, and other key variables, enabling precise process control and optimization.
Integrated sensor technology enhances process visibility, reduces the risk of deviations, and improves product quality and consistency.
Automation and Connectivity:
Next-generation Single Use Assemblies leverage automation and connectivity technologies to streamline biopharmaceutical manufacturing workflows.
Automated features, such as valve actuators, pumps, and mixers, enable hands-free operation and minimize manual intervention, reducing the risk of human error and contamination.
Connectivity capabilities allow for seamless integration with process control systems, enabling remote monitoring, data analysis, and decision-making in real-time.
Modular and Customizable Solutions:
Next-generation Single Use Assemblies offer modular and customizable solutions tailored to the specific needs and requirements of biopharmaceutical manufacturers.
Modular designs allow for easy integration of different components and modules, enabling rapid configuration and reconfiguration of production lines.
Customization options provide flexibility to adapt Single Use Assemblies to unique process requirements, optimizing performance, efficiency, and productivity.
Get More Insights On This Topic: Single Use Assemblies
#Single Use Assemblies#Biopharmaceutical Manufacturing#Disposable Systems#Bioprocessing Solutions#Process Efficiency#Advanced Technology#Modular Design#Quality Assurance
0 notes
Text
Detailed Report on Continuous Bioprocessing Market | BIS Research
Bioprocessing is a branch of biotechnology that involves the use of living organisms or their components to manufacture products. It encompasses various techniques and processes aimed at utilizing biological systems, such as cells, enzymes, or microorganisms, to produce valuable substances like pharmaceuticals, food ingredients, biofuels, and specialty chemicals.
The Global Bioprocessing Market was valued at $250.1 million in 2023 and is expected to reach $1,639.1 million by 2033, growing at a CAGR of 20.68% between 2023 and 2033.
Continuous Bioprocessing Overview
The continuous bioprocessing market can be defined as the segment of the biopharmaceutical industry that focuses on the production and manufacturing of biologics, vaccines, and pharmaceuticals using continuous and uninterrupted processes, which are opposite to traditional batch processing.
This market includes bioreactors, chromatography systems, consumables, filtration systems and devices, and other related products involved in the streamlined and continuous production of biopharmaceutical products such as monoclonal antibodies, vaccines, cell and gene therapy and other applications, with the aim of improving efficiency, reducing production costs.
Grab the free sample page click here
Scope and Importance of Continuous Bioprocessing Market
Several key aspects highlighting its significance
Production of Pharmaceuticals: Bioprocessing is vital for the production of biopharmaceuticals, including vaccines, antibodies, hormones, and therapeutic proteins.
Biofuels and Renewable Energy: Bioprocessing plays a crucial role in the production of biofuels, such as ethanol, biodiesel, and biohydrogen, providing alternatives to fossil fuels.
Food and Beverage Industry: Bioprocessing is used in the production of various food ingredients, enzymes, flavors, and additives.
Agricultural Biotechnology: Bioprocessing is employed in the development of agricultural bioproducts, including biopesticides, biofertilizers, and plant-based pharmaceuticals.
Sustainability and Green Chemistry: Bioprocessing offers sustainable alternatives to traditional chemical synthesis methods, reducing energy consumption, waste generation, and environmental pollution
Bioprocessing plays a pivotal role in advancing biotechnology, driving economic growth, and addressing global challenges related to health, energy, environment, and food security.
Market Drivers and Trends for Continuous Bioprocessing Market
a) market drivers are as follows
Growing demand for continuous bioprocessing due to flourishing biopharma
Cost reduction with continuous bioprocessing
Increasing adoption of new technologies like single use bioprocessing techniques
b) market trends are as follows
Digitalization of continuous bioprocessing by the biopharmaceutical industry
These drivers and trends are shaping the bioprocessing market landscape, driving innovation, investment, and growth in the biotechnology and biopharmaceutical industries.
Applications for Continuous Bioprocessing Market
Monoclonal Antibodies
Vaccines
Cell and gene therapy
Other applications
And many others
Recent Developments in the Bioprocessing Market
• Waters and Sartorius expanded their partnership to develop integrated analytical tools for downstream biomanufacturing following their successful collaboration in upstream processes.
• Sartorius and Repligen Corporation launched an integrated system with Biostat STR and XCell ATF for upstream process intensification.
Visit our Life Sciences and Biopharma Vertical page for better understanding
Key Players in the market
• 3M
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Sartorius AG
• Danaher Corporation
Key Questions Answered
Q What is the estimated global market size for the continuous bioprocessing market?
Q What future trends are expected in the continuous bioprocessing market?
Q What does the supply chain of the continuous bioprocessing market look like?
QWhat does the value chain of the continuous bioprocessing market look like?
Q What is the regulatory framework within the continuous bioprocessing market?
Q What is the patent analysis trend based on country and year in the continuous bioprocessing market?
Q How has the COVID-19 outbreak affected the future trajectory of the continuous bioprocessing market?
Q What are the next frontiers in the continuous bioprocessing market?
Conclusion
In conclusion, the global continuous bioprocessing market is poised for significant growth and innovation in the coming years. With increasing demand for biopharmaceuticals, coupled with the advantages offered by continuous bioprocessing such as enhanced productivity, reduced costs, and improved quality control, the market is witnessing a paradigm shift in biomanufacturing practices.
0 notes
Last Seen Blogs
annfryart
Ann Fry
christacarleton
Christa Carleton
bommi-e
bommie edits
blacktabbygames
Black Tabby Games
mzallaghi
Untitled